Stratulat Albulescu Attorneys at Law acted as co-counsel for The Rohatyn Group (“TRG”) on the investment in Amethyst Radiotherapy Limited (“Amethyst”), resulting in the former gaining co-control of the Company alongside the two co-founders.
Founded in 2010, Amethyst is one of the largest operators of radiotherapy clinics in Europe that provides radiotherapy treatment for most types of common cancers. The company operates nine centers across France, Romania, Italy, Poland and Austria, treating over 10,000 patients annually. Amethyst is present in Romania since 2012 and operates two radiotherapy centers in Bucharest and Cluj. TRG’s investment will be used to accelerate the growth of the Amethyst across Europe through the roll-up of clinics, the development of greenfield centers and outsourcing partnerships with hospitals. The transaction’s importance resides in the multiple jurisdictions involved and also in the capabilities and potential for growth of the target company, with further potential to attract investors and financing considering its business.
Founded in 2002, TRG is an emerging markets focused asset management firm headquartered in New York, with offices around the globe including Boston, Singapore, Rotorua, Mumbai, New Delhi, London, Buenos Aires, Montevideo, Lima and São Paulo. In October 2018, TRG completed another transaction on the Romanian market by acquiring a well-known retailer of pet supplies.
International law firm Baker McKenzie was the lead legal adviser on the deal.
The team led by Managing Partner Silviu Stratulat also included Managing Associate Cristina Man and Partner Ana Maria Kusak (who handled the merger clearance procedure).
